Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.21 USD | +2.41% | -27.94% | -35.65% |
15/05 | HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating | MT |
14/05 | Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.65% | 192M | |
+9.95% | 115B | |
+11.98% | 106B | |
-2.59% | 21.96B | |
-12.67% | 21.87B | |
-5.29% | 19.21B | |
-3.84% | 18.08B | |
-38.57% | 17.71B | |
+7.12% | 14.32B | |
+35.11% | 12.42B |
- Stock Market
- Equities
- FENC Stock
- News Fennec Pharmaceuticals Inc.
- Transcript : Fennec Pharmaceuticals Inc. - Shareholder/Analyst Call